Conservative Treatment for Atypical Endometrial Hyperplasia and Early Endometrial Cancer

NCT06170684 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-12-14

No results posted yet for this study

Summary

Exploring the efficacy and pregnancy outcomes of conservative treatment for atypical endometrial hyperplasia and endometrial cancer. Study the factors related to predicting treatment efficacy.

Conditions

  • Atypical Endometrial Hyperplasia and Endometrial Cancer

Sponsors & Collaborators

  • Beijing Obstetrics and Gynecology Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-31
Primary Completion
2024-01-31
Completion
2024-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06170684 on ClinicalTrials.gov